Literature DB >> 1099982

Activity of minocycline against Acinetobacter calcoaceticus var. anitratus (syn. Herellea vaginicola) and Serratia marcescens.

E G Maderazo, R Quintiliani, R C Tilton, R Bartlett, N C Joyce, V T Andriole.   

Abstract

The activity of minocycline and tetracycline against 23 isolates of Acinetobacter calcoaceticus var. anitratus (syn. Herellea vaginicola) and 178 strains of Serratia marcescens was determined by disk and microdilution methods. The results indicate that minocycline is highly active against this species of Acinetobacter, all but one strain being inhibited by 0.007 mug of the antibiotic per ml. Tetracycline was also active, though to a lesser degree, against A. calcoaceticus. Of the 178 strains of S. marcescens tested, only seven (3.9%) had a minimum inhibitory concentration of 2 mug or less of minocycline per ml. Tetracycline was less active than minocycline against S. marcescens; with 2 mug of tetracycline per ml, only 2 of 152 (1.3%) strains were inhibited. At concentrations of 8 and 16 mug of minocycline per ml, which can be achieved in the urine with the usual doses, 44.9 and 63.5% of S. marcescens strains were inhibited, which implies its possible usefulness for the therapy of urinary tract infection due to this organism.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1099982      PMCID: PMC429260          DOI: 10.1128/AAC.8.1.54

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Nosocomial urinary tract infection with Serratia marcescens: an epidemiologic study.

Authors:  D G Maki; C G Hennekens; C W Phillips; W V Shaw; J V Bennett
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

2.  Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro.

Authors:  N H Steigbigel; C W Reed; M Finland
Journal:  Am J Med Sci       Date:  1968-03       Impact factor: 2.378

3.  Cross-infection with Serratia marcescens in an intensive-therapy unit.

Authors:  J L Whitby; J N Blair; A Rampling
Journal:  Lancet       Date:  1972-07-15       Impact factor: 79.321

4.  Absorption and excretion of five tetracycline analogues in normal young men.

Authors:  N H Steigbigel; C W Reed; M Finland
Journal:  Am J Med Sci       Date:  1968-05       Impact factor: 2.378

5.  Serratia marcescens septicemia. A new threat in surgery.

Authors:  W A Altemeier; W R Culbertson; W D Fullen; J J McDonough
Journal:  Arch Surg       Date:  1969-08

6.  Serratia sp. infections in cancer patients.

Authors:  G P Bodey; V Rodriguez; J P Smith
Journal:  Cancer       Date:  1970-01       Impact factor: 6.860

7.  Microdilution antibiotic susceptibility test: examination of certain variables.

Authors:  R C Tilton; L Lieberman; E H Gerlach
Journal:  Appl Microbiol       Date:  1973-11

8.  Antibiotic susceptibility of gram-negative bacilli isolated from blood cultures. Results of tests with 35 agents and strains from 169 patients at Boston City Hospital during 1972.

Authors:  J E McGowan; C Garner; C Wilcox; M Finland
Journal:  Am J Med       Date:  1974-08       Impact factor: 4.965

9.  Serratia marcescens bacteremia. Clinical observations and studies of precipitin reactions.

Authors:  Jackson G Crowder; Gareth H Gilkey; Arthur C White
Journal:  Arch Intern Med       Date:  1971-08

10.  In vitro antibacterial activity of minocycline and effect of agar medium utilized in its susceptibility testing.

Authors:  J A Washington; P K Yu; W J Martin
Journal:  Appl Microbiol       Date:  1970-02
View more
  8 in total

1.  In-use evaluation of a prediluted quantitative antibiotic susceptibility test device.

Authors:  R C Tilton; H D Isenberg
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

2.  In vitro activity of three tetracycline antibiotics against Acinetobacter calcoaceticus subsp. anitratus.

Authors:  J V Crues; B E Murray; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

3.  In vitro and in vivo activities of minocycline and other antibiotics against Acinetobacter (Herellea-Mima).

Authors:  N A Kuck
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

4.  Bacteriuria caused by Acinetobacter calcoaceticus biovars in a normal population and in general practice.

Authors:  S Hoffmann; C E Mabeck; R Vejlsgaard
Journal:  J Clin Microbiol       Date:  1982-09       Impact factor: 5.948

5.  In vitro activity of antimicrobial agents on Legionnaires disease bacterium.

Authors:  C Thornsberry; C N Baker; L A Kirven
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

6.  Susceptibility of Acinetobacter calcoaceticus var. anitratus (Herellea vaginicola) to minocycline.

Authors:  J Z Montgomerie; M J Pickett; R N Yoshimori; A W Chow; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

7.  Laboratory investigation of hospital outbreak caused by two different multiresistant Acinetobacter calcoaceticus subsp. anitratus strains.

Authors:  J Vila; M Almela; M T Jimenez de Anta
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

8.  A common source outbreak of Acinetobacter pulmonary infections traced to Wright respirometers.

Authors:  B A Cunha; J J Klimek; J Gracewski; J C McLaughlin; R Quintiliani
Journal:  Postgrad Med J       Date:  1980-03       Impact factor: 2.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.